Bacil Pharma Fund Raise of ₹50 Cr

Bacil Pharma Other Announcement

Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.

Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr

Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.

Key figure

Net loss ₹0.1 Cr

Bacil Pharma Management Change

Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.

Bacil Pharma Board Meeting Date

Bacil Pharma will hold a board meeting on October 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.

Bacil Pharma Annual Report

Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.

Bacil Pharma Annual General Meeting

Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.

MosChip Technologies Fund Raise of ₹112.2 Cr

MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.

Value

₹112.2 Cr

Cholamandalam Investment & Finance Company Fund Raise

Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.

Bodhi Tree Multimedia Fund Raise

Bodhi Tree Multimedia's EOGM on October 28, 2026, sought approval for a qualified institutions placement. The filing states no issue size.

Avalon Technologies Fund Raise of ₹425 Cr

Avalon Technologies' board approved a preferential warrant issue to Zollner Elektronik AG worth about ₹425 Crore. Shareholder approval is required at an EGM on 21 November 2026.

Value

₹425.0 Cr

Execution

Warrants exercisable within 18 months from allotment

Sealmatic India Fund Raise of ₹15.01 Cr

Sealmatic India's board approved a ₹15.01 Crore preferential issue of 3,61,620 equity shares at ₹415 to two non-promoter investors. Shareholder approval at EGM is pending.

Value

₹15.01 Cr

Sky Gold and Diamonds Fund Raise of ₹1,800 Cr

Sky Gold and Diamonds' EGM on 18 November 2026 seeks approval to raise up to ₹1,800 crore via equity-linked securities. Remote e-voting closes 17 November 2026.

Value

₹1,800 Cr